Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, Yoshimoto T, Miyawaki S, Clausen T, Bang OY, Steinberg GK, Tournier-Lasserve E, Koizumi A.
Lancet Neurol. 2022 Aug;21(8):747-758. doi: 10.1016/S1474-4422(22)00165-X. Epub 2022 May 20.
PMID:35605621
Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association/American Stroke Association.
Gonzalez NR, Amin-Hanjani S, Bang OY, Coffey C, Du R, Fierstra J, Fraser JF, Kuroda S, Tietjen GE, Yaghi S; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology.
Stroke. 2023 Oct;54(10):e465-e479. doi: 10.1161/STR.0000000000000443. Epub 2023 Aug 23.
PMID:37609846
Moyamoya disease and moyamoya syndrome.
Scott RM, Smith ER.
N Engl J Med. 2009 Mar 19;360(12):1226-37. doi: 10.1056/NEJMra0804622.
PMID:19297575
Moyamoya disease emerging as an immune-related angiopathy.
Asselman C, Hemelsoet D, Eggermont D, Dermaut B, Impens F.
RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway.
Ye F, Niu X, Liang F, Dai Y, Liang J, Li J, Wu X, Zheng H, Qi T, Sheng W.
Brain. 2023 Nov 2;146(11):4674-4689. doi: 10.1093/brain/awad225.
PMID:37399508
Diagnostic Criteria for Moyamoya Disease - 2021 Revised Version.
Kuroda S, Fujimura M, Takahashi J, Kataoka H, Ogasawara K, Iwama T, Tominaga T, Miyamoto S; Research Committee on Moyamoya Disease (Spontaneous Occlusion of Circle of Willis) of the Ministry of Health, Labor, and Welfare, Japan.
Neurol Med Chir (Tokyo). 2022 Jul 15;62(7):307-312. doi: 10.2176/jns-nmc.2022-0072. Epub 2022 May 25.